FDG PET/CT as a Response Surrogate in Patients with Multiple Myeloma.

被引：0
|
作者：
Kostakoglu, L. [1 ]
Peti, S. [1 ]
Osman, K. [2 ]
Scigliano, E. [2 ]
Heiba, S. [1 ]
Machac, J. [1 ]
Malone, A. [2 ]
Isola, L. [2 ]
机构：
[1] Mt Sinai Med Ctr, Dept Radiol, New York, NY 10029 USA
[2] Mt Sinai Med Ctr, Div Hematol & Oncol, New York, NY 10029 USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S253 / S254
页数：2
相关论文
共 50 条
  • [1] FDG PET/CT as a Response Surrogate in Patients with Multiple Myeloma.
    Kostakoglu, L.
    Peti, S.
    Osman, K.
    Scigliano, E.
    Heiba, S.
    Machac, J.
    Malone, A.
    Isola, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 253 - 254
  • [2] Role of 18f-FDG PET/CT in the management of multiple myeloma.
    Zamagni, E
    Nanni, C
    Tosi, P
    Fanti, S
    Cangini, D
    Castellucci, P
    Tacchetti, P
    Perrone, G
    Ceccolini, M
    Farsad, M
    Baccarani, M
    Cavo, M
    BLOOD, 2005, 106 (11) : 975A - 975A
  • [3] FDG PET/CT in multiple myeloma patients: Is it prognostic?
    Nanni, Cristina
    Zamagni, Elena
    Caroli, Paola
    Lopci, Egesta
    Ambrosini, Valentina
    Perrone, Giulia
    Zanetti, Beatrice
    Brioli, Anna Maria
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [4] 18F-FDG kinetics in patients with multiple myeloma. Evaluation with dynamic PET-CT
    Sachpekidis, C.
    Strauss, L. G.
    Goldschmidt, H.
    Hillengass, J.
    Cheng, C.
    Pan, L.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S374 - S374
  • [5] PET/CT in Multiple Myeloma: Beyond FDG
    Matteucci, Federica
    Paganelli, Giovanni
    Martinelli, Giovanni
    Cerchione, Claudio
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [6] F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study
    Gallicchio, R.
    Nardelli, A.
    Calice, G.
    Guarini, A.
    Guglielmi, G.
    Storto, G.
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 136
  • [7] Utility and prognostic value of 18F-FDG PET/CT scan in patients with newly diagnosed multiple myeloma.
    Aljama, Mohammed A.
    Sidiqi, M. Hasib
    Kumar, Shaji
    Kourelis, Taxiarchis
    Gertz, Morie A.
    Rajkumar, S. Vincent
    Gonsalves, Wilson I.
    Lacy, Martha
    Buadi, Francis
    Kapoor, Prashant
    Dispenzieri, Angela
    Dingli, David
    Leung, Nelson
    Lust, John Anthony
    Hayman, Suzanne R.
    Go, Ronald S.
    Hwa, Lisa
    Kyle, Robert A.
    Warsame, Rahma M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Sarcopenia and metabolic parameters of [18F]-FDG PET/CT in patients with multiple myeloma. Preliminary results.
    Palomar-Munoz, A.
    Hermosa-Garcia, S.
    Sanchez-Rodriguez, I.
    Benavente, Y.
    Jorge-Novoa, J. A.
    Carrero-Vasquez, V.
    Hervas-Sanz, B.
    Garamundi-Grimalt, E.
    Bustamante-Ramirez, G.
    Cabezudo-Perez, E.
    Cortes-Romera, M.
    Casabonne, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S572 - S573
  • [9] FDG-PET/CT and new radiopharmaceuticals in patients with multiple myeloma
    Morales Lozano, M. I.
    Garcia-Velloso, M. J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (02): : 129 - 135
  • [10] FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
    Pandit-Taskar, N.
    Comenzo, R. L.
    Hassoun, H.
    Hoover, E.
    Borkar, S.
    Reidel, E.
    Cohen, A.
    Surti, C.
    Nimer, S. D.
    Landau, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345